戻る Agenda
Session 2 : Advancing Pharmacovigilance: regulatory use of database and Risk Management Plan
Session Chair(s)
Min-Jung Lim, MPharm, RPh
CEO & Senior Pharmacovigilance Consultant, MediSafe, Pharmacovigilance Services, Korea, Republic of
In-sook Park, PhD
Former Director General, Korean Regulatory Science Center, Korea, Republic of
Speaker(s)
Session 2 - 1
Takashi Waki, PhD, RPh
Epidemiologist, Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Session 2 - 2
Bonggi Kim, PhD
Director, Korea Institute of Drug Safety and Risk Management, Korea, Republic of
Session 2 - 3
Jingyu (Julia) Luan, PhD
Executive Regulatory Science Director , AstraZeneca, United States
Ju-Young Shin, PhD
Professor, Sungkyunkwan University, Korea, Republic of
Hyungjin Jung, MD, MBA
Senior Medical Director, Lundbeck Korea, Korea, Republic of
Younglim Kim, PhD
Director General, National Institute of Food & Drug Safety (NIFDS), Korea, Republic of
Nam-Kyong Choi, PhD
Research Professor, Division of Clinical Epidemiology, Seoul National University College of Medicine/Seoul National University Hospital, Korea, Republic of